Citation Impact
Citing Papers
Generation of knock-in primary human T cells using Cas9 ribonucleoproteins
2015 StandoutNobel
Development of GPC2-directed chimeric antigen receptors using mRNA for pediatric brain tumors
2022 StandoutNobel
Chimeric antigen receptor -T cell therapy: Applications and challenges in treatment of allergy and asthma
2019
Chemo-photothermal therapy combination elicits anti-tumor immunity against advanced metastatic cancer
2018
Systematic development of ionizable lipid nanoparticles for placental mRNA delivery using a design of experiments approach
2023 StandoutNobel
The promise and challenge of therapeutic genome editing
2020 StandoutNatureNobel
Engineering precision nanoparticles for drug delivery
2020 Standout
CD33-specific chimeric antigen receptor T cells exhibit potent preclinical activity against human acute myeloid leukemia
2015
Elements of cancer immunity and the cancer–immune set point
2017 StandoutNature
JAK Inhibition with Ruxolitinib versus Best Available Therapy for Myelofibrosis
2012 Standout
Modular and tunable biological feedback control using a de novo protein switch
2019 StandoutNatureNobel
VISTA is an inhibitory immune checkpoint that is increased after ipilimumab therapy in patients with prostate cancer
2017 StandoutNobel
Development of next generation adeno-associated viral vectors capable of selective tropism and efficient gene delivery
2015
CAR T Cell Therapy for Solid Tumors: Bright Future or Dark Reality?
2020
Toxicity and management in CAR T-cell therapy
2016
Applications of CRISPR-Cas Enzymes in Cancer Therapeutics and Detection
2018 StandoutNobel
Macrophages in immunoregulation and therapeutics
2023 Standout
The immune contexture in cancer prognosis and treatment
2017 Standout
Interdependent IL-7 and IFN-γ signalling in T-cell controls tumour eradication by combined α-CTLA-4+α-PD-1 therapy
2016 StandoutNobel
Amniotic fluid stabilized lipid nanoparticles for in utero intra-amniotic mRNA delivery
2021 StandoutNobel
Delivery technologies for cancer immunotherapy
2019 Standout
Chimeric antigen receptors: driving immunology towards synthetic biology
2016
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
Bacterial virulence proteins as tools to rewire kinase pathways in yeast and immune cells
2012 Nature
Nasopharyngeal carcinoma
2015 Standout
Targeting the IL-6/JAK/STAT3 signalling axis in cancer
2018 Standout
Long-Term Stability and Safety of Transgenic Cultured Epidermal Stem Cells in Gene Therapy of Junctional Epidermolysis Bullosa
2013
Adoptive T-cell Transfer and Chemotherapy in the First-line Treatment of Metastatic and/or Locally Recurrent Nasopharyngeal Carcinoma
2013
The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans
2021 StandoutNobel
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
2017 Standout
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
2023 Standout
Adeno-associated virus vector as a platform for gene therapy delivery
2019 Standout
The Third International Consensus Guidelines on the Management of Cytomegalovirus in Solid-organ Transplantation
2018 Standout
CAR-T cell therapy: current limitations and potential strategies
2021 Standout
Respiratory Virus Infections in Hematopoietic Cell Transplant Recipients
2019
Alpharetroviral self-inactivating vectors produced by a superinfection-resistant stable packaging cell line allow genetic modification of primary human T lymphocytes
2016 StandoutNobel
Targeting immune cells for cancer therapy
2019
Loss of IFN-γ Pathway Genes in Tumor Cells as a Mechanism of Resistance to Anti-CTLA-4 Therapy
2016 StandoutNobel
Integration-Free iPS Cells Engineered Using Human Artificial Chromosome Vectors
2011 StandoutNobel
Chimeric antigen receptor T-cell therapy — assessment and management of toxicities
2017 Standout
The Emerging Role of In Vitro-Transcribed mRNA in Adoptive T Cell Immunotherapy
2019 StandoutNobel
A guide to cancer immunotherapy: from T cell basic science to clinical practice
2020 Standout
Current Approaches of Photothermal Therapy in Treating Cancer Metastasis with Nanotherapeutics
2016
Myeloid Cells as Clinical Biomarkers for Immune Checkpoint Blockade
2020
TK.007: A Novel, Codon-Optimized HSVtk(A168H) Mutant for Suicide Gene Therapy
2010
Targeting Innate Immunity in Cancer Therapy
2021
Adoptive Immunotherapy for Cancer or Viruses
2014
Computational design of a synthetic PD-1 agonist
2021 StandoutNobel
Gold nanoparticle‐mediated photothermal therapy: applications and opportunities for multimodal cancer treatment
2017
Photothermal therapy and photoacoustic imaging via nanotheranostics in fighting cancer
2018 Standout
Tumor-Associated Macrophages in Pancreatic Ductal Adenocarcinoma: Therapeutic Opportunities and Clinical Challenges
2021
Cancer suicide gene therapy with TK.007: superior killing efficiency and bystander effect
2011
Design and development of therapies using chimeric antigen receptor‐expressing T cells
2013
Advances in skin grafting and treatment of cutaneous wounds
2014 StandoutScience
Tertiary lymphoid structures, drivers of the anti‐tumor responses in human cancers
2016
Adoptive cell transfer as personalized immunotherapy for human cancer
2015 StandoutScience
A highly compact epitope-based marker/suicide gene for easier and safer T-cell therapy
2014
Human Coronaviruses and Other Respiratory Viruses: Underestimated Opportunistic Pathogens of the Central Nervous System?
2019 Standout
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
CRISPR-enhanced engineering of therapy-sensitive cancer cells for self-targeting of primary and metastatic tumors
2018
Ionizable lipid nanoparticles for in utero mRNA delivery
2021 StandoutNobel
How I treat EBV lymphoproliferation
2009
Going viral: chimeric antigen receptor T‐cell therapy for hematological malignancies
2014
State-of-the-Art Lentiviral Vectors for Research Use: Risk Assessment and Biosafety Recommendations
2009
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Safety and clinical efficacy of rapidly-generated trivirus-directed T cells as treatment for adenovirus, EBV, and CMV infections after allogeneic hematopoietic stem cell transplant
2013
CAR T Cell Therapy: A Game Changer in Cancer Treatment
2016
Tumor indoleamine 2,3-dioxygenase (IDO) inhibits CD19-CAR T cells and is downregulated by lymphodepleting drugs
2015
Activity of Broad-Spectrum T Cells as Treatment for AdV, EBV, CMV, BKV, and HHV6 Infections after HSCT
2014
Plasmon-Mediated Generation of Reactive Oxygen Species from Near-Infrared Light Excited Gold Nanocages for Photodynamic Therapy in Vitro
2014
Poly(N‐phenylglycine)‐Based Nanoparticles as Highly Effective and Targeted Near‐Infrared Photothermal Therapy/Photodynamic Therapeutic Agents for Malignant Melanoma
2016
Development of individualized anti-metastasis strategies by engineering nanomedicines
2015
Hematological Problems in Pediatric Intensive Care
2013 Standout
Nontoxic nanopore electroporation for effective intracellular delivery of biological macromolecules
2019 StandoutNobel
Works of Serena Perna being referenced
Interleukin-7 Mediates Selective Expansion of Tumor-redirected Cytotoxic T Lymphocytes (CTLs) without Enhancement of Regulatory T-cell Inhibition
2013
Interleukin 15 Provides Relief to CTLs from Regulatory T Cell–Mediated Inhibition: Implications for Adoptive T Cell–Based Therapies for Lymphoma
2012
Transcriptional Enhancers Induce Insertional Gene Deregulation Independently From the Vector Type and Design
2009
Graft-versus-leukemia Effect of HLA-haploidentical Central-memory T-cells Expanded With Leukemic APCs and Modified With a Suicide Gene
2013
The Suicide Gene Therapy Challenge: How to Improve a Successful Gene Therapy Approach
2007
Elimination of Metastatic Melanoma Using Gold Nanoshell-Enabled Photothermal Therapy and Adoptive T Cell Transfer
2013
Early transduction produces highly functional chimeric antigen receptor-modified virus-specific T-cells with central memory markers: a Production Assistant for Cell Therapy (PACT) translational application
2015
Rapidly Generated Multivirus-specific Cytotoxic T Lymphocytes for the Prophylaxis and Treatment of Viral Infections
2012
Phase II multi-institutional study of nivolumab (Nivo), cabiralizumab (Cabira), and stereotactic body radiotherapy (SBRT) for locally advanced unresectable pancreatic cancer (LAUPC).
2019
A randomized phase II study of cabiralizumab (cabira) + nivolumab (nivo) ± chemotherapy (chemo) in advanced pancreatic ductal adenocarcinoma (PDAC).
2019
Pharmacodynamics (PD) and genomic profiling of pts treated with cabiralizumab (cabira) + nivolumab (NIVO) provide evidence of on-target tumor immune modulations and support future clinical applications.
2018
Genomic Loss of the Mismatched HLA Locus in Leukemia Is a Major Mechanism of in Vivo Escape from T Cell Immunosurveillance Following Haploidentical HSCT
2008